ITHEMYC

Novel immunotherapies for tuberculosis and other mycobacterial diseases

Project details

Unibo Team Leader: Marco Viceconti

Unibo involved Department/s:
Dipartimento di Ingegneria Industriale

Coordinator:
Stichting Tuberculosis Vaccine Initiative-Tbvi(Netherlands)

Other Participants:
ALMA MATER STUDIORUM - Università di Bologna (Italy)

Total Eu Contribution: Euro (EUR) 5.948.169,00
Project Duration in months: 48
Start Date: 01/06/2023
End Date: 31/05/2027

Cordis webpage

This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101080462 This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101080462